Barion Pixel

Hírek

FDA rejects Capricor Therapeutics cell therapy for Duchenne muscular dystrophy

The Food and Drug Administration rejected Capricor Therapeutics' cell therapy, deramiocel, intended for patients with Duchenne muscular dystrophy. Regulators blocked the treatment after two randomized clinical trials failed to demonstrate that the therapy could prevent heart failure or preserve musc